Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4135571000168111 | Brevinor 28 Day (ethinylestradiol 35 microgram + norethisterone 500 microgram) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4135581000168114 | Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4143101000168112 | Brevinor 28 Day (ethinyloestradiol 35 microgram + norethisterone 500 microgram) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | has manufactured dose form | uncoated tablet | false | Inferred relationship | Some | ||
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | Is a | norethisterone 500 microgram + ethinylestradiol 35 microgram tablet | true | Inferred relationship | Some | ||
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | has intended active ingredient | ethinylestradiol | true | Inferred relationship | Some | 64252588 | |
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | has Australian BoSS | norethisterone | true | Inferred relationship | Some | 1803422462 | |
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | Is a | Brevinor 28 Day | true | Inferred relationship | Some | ||
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | has intended active ingredient | norethisterone | true | Inferred relationship | Some | 1803422462 | |
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | has unit of use | tablet | true | Inferred relationship | Some | 1803422463 | |
| Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | has Australian BoSS | ethinylestradiol | true | Inferred relationship | Some | 64252588 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brevinor 28 Day (21 x 500 microgram/35 microgram tablets, 7 x inert tablets), 4 x 28 | has TPUU | True | Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 3 |
| Brevinor 28 Day (21 x 500 microgram/35 microgram tablets, 7 x inert tablets), 28 | has TPUU | True | Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 1 |
| Brevinor 28 Day (21 x 500 microgram/35 microgram tablets, 7 x inert tablets), 28, blister pack | has TPUU | True | Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 2 |
| Brevinor 28 Day (21 x 500 microgram/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | has TPUU | True | Brevinor 28 Day (norethisterone 500 microgram + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 2 |
Reference Sets
Trade product unit of use reference set
FHIR